Tech Meridian
← ENTITY INDEX
TOPIC · ENTITY #19601
Related event timeline, sources and context from the news index.
OpenAI is acquiring Orchestra Bio to integrate AI-powered operations into life‑sciences R&D, aiming to help biopharma teams accelerate drug development and advance new treatments. The move positions OpenAI to extend its AI capabilities into laboratory and research workflows in the life‑sciences sector.
Amulya Vishwanath, who led product marketing for NVIDIA’s robotics platforms for seven years, has founded Techable VC and is writing early checks into what she calls 'physical AI' — covering robotics, materials science and life sciences. She argues physical AI includes molecules, materials and medicines as well as machines, and rejects the idea that a single general foundation model will instantly produce a ChatGPT-style breakthrough for robotics.
Allow Google Analytics to measure visits? It stays off until you choose. You can change your choice at any time.